04 August 2022
Portfolio insights
Company in focus: EUSA Pharma
EUSA Pharma, a global, specialty in-licensing pharmaceutical company focused on oncology and rare diseases, is PIN’s largest ever single company exit after it was sold in December 2021.
04 August 2022
Portfolio insights
EUSA Pharma, a global, specialty in-licensing pharmaceutical company focused on oncology and rare diseases, is PIN’s largest ever single company exit after it was sold in December 2021.